Itovebi Combo Boosts Progression-Free Survival in PIK3CA-Mutated HR-Positive, HER2-Negative Metastatic Breast Cancer
Credit: Sara_P | stock.adobe.com Data from the Phase III INAVO120 trial (NCT04191499) published in The New England Journal of Medicine…
